{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,10]],"date-time":"2026-07-10T02:10:31Z","timestamp":1783649431364,"version":"3.55.0"},"reference-count":23,"publisher":"Elsevier BV","issue":"7","license":[{"start":{"date-parts":[[2019,7,1]],"date-time":"2019-07-01T00:00:00Z","timestamp":1561939200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,7,1]],"date-time":"2019-07-01T00:00:00Z","timestamp":1561939200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"name":"Research Program on Emerging"},{"DOI":"10.13039\/100009619","name":"Japan Agency for Medical Research and Development","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100009619","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100009619","name":"AMED","doi-asserted-by":"publisher","award":["JP18fk0108041"],"award-info":[{"award-number":["JP18fk0108041"]}],"id":[{"id":"10.13039\/100009619","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jiac-j.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Infection and Chemotherapy"],"published-print":{"date-parts":[[2019,7]]},"DOI":"10.1016\/j.jiac.2019.02.018","type":"journal-article","created":{"date-parts":[[2019,3,21]],"date-time":"2019-03-21T09:12:05Z","timestamp":1553159525000},"page":"537-542","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":15,"title":["Positivity rate of interferon-\u03b3 release assays for estimating the prevalence of latent tuberculosis infection in renal transplant recipients in Japan"],"prefix":"10.1016","volume":"25","author":[{"given":"Hidetoshi","family":"Igari","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Naotake","family":"Akutsu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Satoru","family":"Ishikawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiromichi","family":"Aoyama","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kazunori","family":"Otsuki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masayuki","family":"Hasegawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michihiro","family":"Maruyama","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mizue","family":"Tsuyuzaki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kiminori","family":"Suzuki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kenichi","family":"Saigo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jiac.2019.02.018_bib1","first-page":"1352","article-title":"Preventive chemotherapy. Where has it got us? Where to go next?","volume":"12","author":"Landry","year":"2008","journal-title":"Int J Tuberc Lung Dis"},{"key":"10.1016\/j.jiac.2019.02.018_bib2","unstructured":"World Health Organization. Latent TB Infection: updated and consolidated guidelines for programmatic management https:\/\/www.who.int\/tb\/publications\/2018\/latent-tuberculosis-infection\/en\/ [accessed 03 July 2018]."},{"key":"10.1016\/j.jiac.2019.02.018_bib3","doi-asserted-by":"crossref","first-page":"1567","DOI":"10.1093\/jac\/dku562","article-title":"Isoniazid treatment to prevent TB in kidney and pancreas transplant recipients based on an interferon-\u03b3-releasing assay: an exploratory randomized controlled trial","volume":"70","author":"Kim","year":"2015","journal-title":"J\u00a0Antimicrob Chemother"},{"key":"10.1016\/j.jiac.2019.02.018_bib4","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1111\/j.1399-3062.2010.00495.x","article-title":"Diagnostic usefulness of a T cell-based assay for latent tuberculosis infection in kidney transplant candidates before transplantation","volume":"12","author":"Kim","year":"2010","journal-title":"Transpl Infect Dis"},{"key":"10.1016\/j.jiac.2019.02.018_bib5","doi-asserted-by":"crossref","first-page":"1441","DOI":"10.1056\/NEJMcp1005750","article-title":"Clinical practice. LTBI in the United States","volume":"364","author":"Horsburgh","year":"2011","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jiac.2019.02.018_bib6","doi-asserted-by":"crossref","first-page":"1927","DOI":"10.1111\/j.1600-6143.2011.03625.x","article-title":"A\u00a0prospective longitudinal study evaluating the usefulness of a T-cell-based assay for latent tuberculosis infection in kidney transplant recipients","volume":"11","author":"Kim","year":"2011","journal-title":"Am J Transplant"},{"key":"10.1016\/j.jiac.2019.02.018_bib7","unstructured":"World Health Organization. WHO end TB strategy https:\/\/www.who.int\/tb\/post2015_strategy\/en\/ [accessed 03 July 2018]."},{"key":"10.1016\/j.jiac.2019.02.018_bib8","doi-asserted-by":"crossref","first-page":"928","DOI":"10.1183\/09031936.00214014","article-title":"Towards tuberculosis elimination: an action framework for low-incidence countries","volume":"45","author":"L\u00f6nnroth","year":"2015","journal-title":"Eur Respir J"},{"key":"10.1016\/j.jiac.2019.02.018_bib9","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1183\/09031936.00205512","article-title":"Old ideas to innovate tuberculosis control: preventive treatment to achieve elimination","volume":"42","author":"Diel","year":"2013","journal-title":"Eur Respir J"},{"key":"10.1016\/j.jiac.2019.02.018_bib10","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1016\/j.jiac.2017.04.002","article-title":"Comparison of interferon-\u03b3 release assays, QuantiFERON TB-GIT and T-Spot.TB, in renal transplantation","volume":"23","author":"Ishikawa","year":"2017","journal-title":"J\u00a0Infect Chemother"},{"key":"10.1016\/j.jiac.2019.02.018_bib11","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1164\/rccm.201203-0430OC","article-title":"Test variability of the QuantiFERON-TB gold in-tube assay in clinical practice","volume":"187","author":"Metcalfe","year":"2013","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.jiac.2019.02.018_bib12","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1586\/eri.12.150","article-title":"IFN-\u03b3 release assay versus tuberculin skin test for monitoring TB infection in healthcare workers","volume":"11","author":"Nienhaus","year":"2013","journal-title":"Expert Rev Anti Infect Ther"},{"key":"10.1016\/j.jiac.2019.02.018_bib13","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12995-016-0148-z","article-title":"QFT-Plus: a plus in variability? - Evaluation of new generation IGRA in serial testing of students with a migration background in Germany","volume":"12","author":"Knierer","year":"2017","journal-title":"J\u00a0Occup Med Toxicol"},{"key":"10.1016\/j.jiac.2019.02.018_bib14","doi-asserted-by":"crossref","first-page":"1168","DOI":"10.1164\/rccm.201405-0967OC","article-title":"Risk assessment of tuberculosis in immunocompromised patients. A TBNET study","volume":"190","author":"Sester","year":"2014","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.jiac.2019.02.018_bib15","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1378\/chest.11-0992","article-title":"Challenges of interferon-\u03b3 release assay conversions in serial testing of health-care workers in a TB control program","volume":"142","author":"Fong","year":"2012","journal-title":"Chest"},{"key":"10.1016\/j.jiac.2019.02.018_bib16","first-page":"365","article-title":"Estimation of positive rates of interferon gamma release assay by age group","volume":"92","author":"Kato","year":"2017","journal-title":"Kekkaku"},{"key":"10.1016\/j.jiac.2019.02.018_bib17","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1097\/TP.0b013e3181ecea8d","article-title":"Tuberculosis in renal transplant recipients: the evidence for prophylaxis","volume":"90","author":"Currie","year":"2010","journal-title":"Transplantation"},{"key":"10.1016\/j.jiac.2019.02.018_bib18","doi-asserted-by":"crossref","first-page":"5217","DOI":"10.4049\/jimmunol.167.9.5217","article-title":"Direct ex\u00a0vivo analysis of antigenspecific IFN-gamma-secreting CD4 T cells in Mycobacterium tuberculosis-infected individuals: associations with clinical disease state and effect of treatment","volume":"167","author":"Pathan","year":"2001","journal-title":"J\u00a0Immunol"},{"key":"10.1016\/j.jiac.2019.02.018_bib19","doi-asserted-by":"crossref","first-page":"754","DOI":"10.1086\/381754","article-title":"Use of a T cell-based assay for monitoring efficacy of antituberculosis therapy","volume":"38","author":"Carrara","year":"2004","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.jiac.2019.02.018_bib20","doi-asserted-by":"crossref","first-page":"1301","DOI":"10.1086\/429245","article-title":"Enzyme-linked immunospot assay responses to early secretory antigenic target 6, culture filtrate protein 10, and purified protein derivative among children with tuberculosis: implications for diagnosis and monitoring of therapy","volume":"40","author":"Nicol","year":"2005","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.jiac.2019.02.018_bib21","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1111\/j.1399-3062.2007.00271.x","article-title":"The risk factors and laboratory diagnostics for post renal transplant tuberculosis: a case-control, country-wide study on definitive cases","volume":"10","author":"Basiri","year":"2008","journal-title":"Transpl Infect Dis"},{"key":"10.1016\/j.jiac.2019.02.018_bib22","doi-asserted-by":"crossref","first-page":"1657","DOI":"10.1086\/599035","article-title":"Spanish Network for Research in Infectious Diseases. Tuberculosis after solid-organ transplant: incidence, risk factors, and clinical characteristics in the RESITRA (Spanish Network of Infection in Transplantation) cohort","volume":"48","author":"Torre-Cisneros","year":"2009","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.jiac.2019.02.018_bib23","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1111\/j.1399-3062.2006.00147.x","article-title":"Mycobacterium tuberculosis infection following renal transplantation in Taiwan","volume":"8","author":"Chen","year":"2006","journal-title":"Transpl Infect Dis"}],"container-title":["Journal of Infection and Chemotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1341321X19300613?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1341321X19300613?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,22]],"date-time":"2025-10-22T18:58:42Z","timestamp":1761159522000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1341321X19300613"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,7]]},"references-count":23,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2019,7]]}},"alternative-id":["S1341321X19300613"],"URL":"https:\/\/doi.org\/10.1016\/j.jiac.2019.02.018","relation":{},"ISSN":["1341-321X"],"issn-type":[{"value":"1341-321X","type":"print"}],"subject":[],"published":{"date-parts":[[2019,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Positivity rate of interferon-\u03b3 release assays for estimating the prevalence of latent tuberculosis infection in renal transplant recipients in Japan","name":"articletitle","label":"Article Title"},{"value":"Journal of Infection and Chemotherapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jiac.2019.02.018","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Japanese Society of Chemotherapy and The Japanese Association for Infectious Diseases. Published by Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}